Uploaded March 2018 | Updated September 2026, 2 weeks ago
Dan Sobek, Chief Commercialization Officer of Kernel, is working on next-generation brain interfaces that aim to treat neurological conditions like Parkinson’s Disease, as well as mental and degenerative illnesses like depression and Alzheimer’s. In parallel, the company is also developing consumer-grade devices that are able to “listen” to the brain and gather information. Watch Dan's 2017 TEDMED Hive Talk to find out how Kernel is accessing and then interpreting the brain’s complexities in an effort to develop applications to “illuminate the mechanisms of intelligence and extend cognition.”
Dan Sobek, Chief Commercialization Officer of Kernel, is working on next-generation brain interfaces that aim to treat neurological conditions like Parkinson’s Disease, as well as mental and degenerative illnesses like depression and Alzheimer’s. In parallel, the company is also developing consumer-grade devices that are able to “listen” to the brain and gather information. Watch Dan's 2017 TEDMED Hive Talk to find out how Kernel is accessing and then interpreting the brain’s complexities in an effort to develop applications to “illuminate the mechanisms of intelligence and extend cognition.”
